Starget Pharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $18M

  • Investors
  • 8

Starget Pharma General Information

Description

Operator of a biotechnology company intended to specialize in the diagnosis and targeted treatment of cancer using targeted radioactive radiation. The company's research is in the development of molecules that serve as a vector for the targeted transfer of radioactive isotopes to cancerous tumors, where there is an unmet medical need, enabling doctors and medical practitioners to provide effective treatment for cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rehov Snir 26
  • Ramat HaSharon 4704087
  • Israel
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Rehov Snir 26
  • Ramat HaSharon 4704087
  • Israel

Starget Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Starget Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 18-Feb-2026 $18M Completed Clinical Trials - Phase 1
5. Seed Round Completed Clinical Trials - Phase 1
4. Seed Round 28-Oct-2024 Completed Clinical Trials - Phase 1
3. Corporate 08-Dec-2019 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jul-2019 Completed Startup
To view Starget Pharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Starget Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to specialize in the diagnosis and targeted treatment of cancer using targe
Drug Discovery
Ramat HaSharon, Israel
18 As of 2026

North Melbourne, Australia
 

Rueil-Malmaison, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Starget Pharma Competitors (2)

One of Starget Pharma’s 2 competitors is Telix Pharmaceuticals, a Formerly VC-backed company based in North Melbourne, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Telix Pharmaceuticals Formerly VC-backed North Melbourne, Australia
Advanced Accelerator Applications Formerly VC-backed Rueil-Malmaison, France
You’re viewing 2 of 2 competitors. Get the full list »

Starget Pharma Patents

Starget Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026150415-A1 Cyclic cholecystokinin receptor 2 binding peptides Pending 13-Jan-2025
WO-2026083422-A1 Cyclic grpr binding peptides Pending 20-Oct-2024
WO-2026058257-A1 Grpr binding peptides Pending 13-Sep-2024
AU-2022228766-A1 Conformational constrained somatostatin receptor 3 peptide ligands and their conjugates and uses thereof Pending 04-Mar-2021
CA-3208792-A1 Conformational constrained somatostatin receptor 3 peptide ligands and their conjugates and uses thereof Pending 04-Mar-2021 C07K14/655
To view Starget Pharma’s complete patent history, request access »

Starget Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Starget Pharma Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
BRF(Shreveport) Not-For-Profit Venture Capital Minority
Louisiana Economic Development Government Minority
BVM Capital Venture Capital Minority
Cancer Focus Fund Venture Capital Minority
Ilex Medical Corporation Minority
You’re viewing 5 of 8 investors. Get the full list »

Starget Pharma FAQs

  • When was Starget Pharma founded?

    Starget Pharma was founded in 2019.

  • Where is Starget Pharma headquartered?

    Starget Pharma is headquartered in Ramat HaSharon, Israel.

  • What is the size of Starget Pharma?

    Starget Pharma has 18 total employees.

  • What industry is Starget Pharma in?

    Starget Pharma’s primary industry is Drug Discovery.

  • Is Starget Pharma a private or public company?

    Starget Pharma is a Private company.

  • What is Starget Pharma’s current revenue?

    The current revenue for Starget Pharma is .

  • How much funding has Starget Pharma raised over time?

    Starget Pharma has raised $37.3M.

  • Who are Starget Pharma’s investors?

    BRF(Shreveport), Louisiana Economic Development, BVM Capital, Cancer Focus Fund, and Ilex Medical are 5 of 8 investors who have invested in Starget Pharma.

  • Who are Starget Pharma’s competitors?

    Telix Pharmaceuticals and Advanced Accelerator Applications are competitors of Starget Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process